Lipids in inflammasome activation and autoinflammatory disorders

Area of Science:

• Immunology
• Metabolomics
• Genetics

Background:

• Autoinflammatory diseases (AIDs) are rare genetic disorders marked by recurrent fever and inflammation.
• A key feature of AIDs is overactive inflammasome assembly and activation, often due to gene mutations.
• Emerging lipidomics research shows altered lipid metabolism influences inflammasome activity and AID development.

Purpose of the Study:

• To review the role of lipids and their metabolism in inflammasome activation.
• To discuss the impact of lipid dysregulation on the pathogenesis of common AIDs.
• To explore the potential diagnostic and therapeutic implications of lipids in AIDs.

Main Methods:

• Literature review of studies on AIDs, inflammasomes, and lipid metabolism.
• Analysis of lipidomics data in the context of innate immune cell function.
• Synthesis of findings related to familial Mediterranean fever, cryopyrin-associated periodic syndromes, and mevalonate kinase deficiency.

Main Results:

• Dysregulated lipid metabolism, particularly cholesterol and fatty acids, significantly affects inflammasome activation in AIDs.
• Specific lipid alterations are linked to the pathogenesis of major AIDs.
• Lipids may serve as biomarkers for AIDs diagnosis.

Conclusions:

• Lipid metabolism plays a critical role in the pathogenesis of autoinflammatory diseases.
• Targeting lipid metabolism through diet or medication could be a promising therapeutic strategy for AIDs.
• Further research into lipids could unlock new diagnostic and treatment avenues for AIDs.